Gangadhara Reddy Sareddy

Assistant Professor

University of Texas Health Science Center at San Antonio

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Gangadhara Reddy Sareddy is an Assistant Professor at the University of Texas Health Science Center at San Antonio, USA. His research focuses on innovative therapeutic strategies in oncology, particularly concerning glioblastoma, ovarian cancer, and breast cancer, as evidenced by his recent publications on therapeutics targeting LIPA and brain-permeable agents. His work also explores the roles of estrogen and various mediators in cancer progression.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

Augusta University Medical College of Georgia

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gangadhara Reddy Sareddy

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Novel LIPA-Targeted Therapy for Treating Ovarian Cancer

Author Correction: Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress

Sacituzumab Govitecan in patients with breast cancer brain metastases and recurrent glioblastoma: a phase 0 window-of-opportunity trial

Preclinical Development of Brain Permeable ERβ Agonist for the Treatment of Glioblastoma

Development and Characterization of Inducible Astrocyte-Specific Aromatase Knockout Mice

Reticulocalbin 3 Is a Novel Mediator of Glioblastoma Progression

Brain-Derived Estrogen and Neurological Disorders

Inhibition of LIFR Blocks Adiposity-Driven Endometrioid Endometrial Cancer Growth

Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress

Therapeutic Targeting of Ovarian Cancer Stem Cells Using Estrogen Receptor Beta Agonist

Collaborators (7)

Ratna Vadlamudi

Suryavathi Viswanadhapalli

Huan Xie

Hui Yan

Siyuan Zheng

Dong Liang

Darrell Brann

Make your next move.